MedTrace Logo

Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy

NCT06313632 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-05-01

No results posted yet for this study

Summary

PlAcebo versus erector spINae pLane block for mEdical ThoracoScopy Study (PAINLESS). This is a prospective triple-blind, randomized controlled trial that evaluates the efficacy of erector spinae plane block (ESPB) with Bupivacaine in reducing pain after medical thoracoscopy (MT) in addition to monitored anesthesia care vs monitored anesthesia care alone.

Conditions

  • Pleural Disease
  • Postoperative Pain

Interventions

DRUG

Bupivacaine injection

Erector spinae plane block with bupivacaine (0.5%) 30 mL once

DRUG

Placebo

ESP with matching saline placebo

OTHER

Monitored Anesthesia Care

Standard monitored anesthesia care

Sponsors & Collaborators

Principal Investigators

  • Udit Chaddha, MBBS · Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-28
Primary Completion
2025-03-19
Completion
2025-03-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06313632 on ClinicalTrials.gov